investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
M. James You
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
M. James You
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
David H Haussler
Center for Big Data in Translational Genomics
Leukaemia
Michael Gottesman
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Leukaemia
Anthony G Letai
Probing mitochondria and personalizing leukemia therapy with BH3 profiling
Leukaemia
Ronen Marmorstein
Structure and Function of Protein Acetyltransferases
Leukaemia
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Margaret A Goodell
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
Leukaemia
Irving L. Weissman
HSC Diversity, in aging, ontogeny, and transformation
Leukaemia